Vaccine Contract Manufacturing Market Report 2026
Download Free Sample Buy Now
Vaccine Contract Manufacturing Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : January 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Vaccine Contract Manufacturing Market Report 2026

Global Outlook – By Service Type (Fill-Finish, Bulk Product), By Vaccine Type (Inactivated Vaccines, Live-Attenuated Vaccines, RNA (Ribonucleic Acid) Vaccines, Subunit Vaccines, Toxoid-Based Vaccines), By Process (Downstream, Upstream), By Scale Of Operation (Preclinical, Clinical, Commercial), By End-Use (Human Use, Veterinary) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Vaccine Contract Manufacturing Market Overview

• Vaccine Contract Manufacturing market size has reached to $3.88 billion in 2025

• Expected to grow to $6.46 billion in 2030 at a compound annual growth rate (CAGR) of 10.9%

• Growth Driver: Elevated Infectious Disease Cases Propel Expansion In The Vaccine Contract Manufacturing Market

• Market Trend: Strategic Expansion With The Standalone Vaccine Contract Manufacturing Site

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Vaccine Contract Manufacturing Market?

Vaccine contract manufacturing refers to an arrangement for creating vaccines with outside producers, who oversee producing, packing, and labeling vaccines according to the specifications and demands of the contracting business or organization. The primary benefit of vaccine contract manufacturing is that it simplifies production, resulting in cost savings and fewer difficulties.

The main types of services involved in vaccine contract manufacturing are fill-finish and bulk products. Fill-finish refers to the filling and finishing of the manufacturing process of vaccines. In the pharmaceutical industry, finishing refers to the sterilization and standardization of vaccine components into the containers, while filling means simply adding them to containers and sealing them properly. The vaccines produced are inactivated vaccines, live-attenuated vaccines, RNA (ribonucleic acid) vaccines, subunit vaccines, and toxoid-based vaccines. These are prepared by downstream and upstream processes on preclinical, clinical, and commercial scales of operations for human use and veterinary end-users.

Vaccine Contract Manufacturing Market Global Report 2026 Market Report bar graph

What Is The Vaccine Contract Manufacturing Market Size and Share 2026?

The vaccine contract manufacturing market size has grown strongly in recent years. It will grow from $3.88 billion in 2025 to $4.27 billion in 2026 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to expansion of global immunization programs, increasing complexity of vaccine production processes, reliance on specialized contract manufacturers, growth of public-private vaccine partnerships, establishment of large-scale vaccine facilities.

What Is The Vaccine Contract Manufacturing Market Growth Forecast?

The vaccine contract manufacturing market size is expected to see rapid growth in the next few years. It will grow to $6.46 billion in 2030 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to rising demand for rapid vaccine scale-up capabilities, increasing investments in mRNA and next-generation vaccines, expansion of commercial-scale manufacturing, growing focus on regional vaccine self-sufficiency, adoption of advanced bioprocess technologies. Major trends in the forecast period include increasing outsourcing of vaccine production, rising demand for flexible manufacturing capacity, expansion of fill-finish service capabilities, growing focus on regulatory-compliant manufacturing, increasing adoption of single-use bioprocessing systems.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Vaccine Contract Manufacturing Market Segmentation

1) By Service Type: Fill-Finish, Bulk Product

2) By Vaccine Type: Inactivated Vaccines, Live-Attenuated Vaccines, RNA (Ribonucleic Acid) Vaccines, Subunit Vaccines, Toxoid-Based Vaccines

3) By Process: Downstream, Upstream

4) By Scale Of Operation: Preclinical, Clinical, Commercial

5) By End-Use: Human Use, Veterinary

Subsegments:

1) By Fill-Finish: Aseptic Fill-Finish, Lyophilization, Vial Filling, Syringe Filling

2) By Bulk Product: Cell Culture, Microbial Fermentation, Antigen Production, Buffer Preparation

What Is The Driver Of The Vaccine Contract Manufacturing Market?

The rising infectious diseases worldwide are expected to boost the growth of the vaccine contract manufacturing market. Infectious diseases refer to disorders caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites. When there is an outbreak of infectious diseases, such as influenza, measles, or emerging viruses, there is an urgent need for vaccines to prevent further spread. Contract manufacturers can quickly scale up production to respond to these outbreaks. For instance, in October 2024, according to the World Health Organization, a Switzerland-based international public health organization, approximately 8.2 million people were newly diagnosed with tuberculosis in 2023, up from about 7.5 million in 2022, placing tuberculosis as the leading infectious disease killer. Therefore, the rising infectious diseases worldwide are driving the growth of the vaccine contract manufacturing industry.

Key Players In The Global Vaccine Contract Manufacturing Market

Major companies operating in the vaccine contract manufacturing market are Pfizer Inc, Johnson & Johnson, AbbVie Inc., Sanofi, GlaxoSmithKline, Merck KGaA, Moderna, BioNTech, GSK Vaccines, AstraZeneca PLC, Ajinomoto Co. Inc., Lonza Group AG, Catalent Inc., Charles River Laboratories International Inc., Serum Institute of India Pvt. Ltd, Samsung Biologics, WuXi Biologics, Novavax, Sinovac Biotech, Emergent BioSolutions Inc., Bio Farma, Hualan Biological Engineering, BioMARC, Bavarian Nordic A/S, AGC Biologics, IDT Biologika GmbH, Bharat Biotech, Goodwin Biotechnology Inc., Biofabri S.L

Global Vaccine Contract Manufacturing Market Trends and Insights

Major companies operating in the vaccine contract manufacturing market are focusing on the production site opening of vaccine contract manufacturing to sustain their position in the market. Production site opening of vaccine contract manufacturing refers to the establishment of a facility dedicated to the manufacturing and production of vaccines on a contractual basis. For instance, in September 2023, WuXi Vaccines, a China-based contract development and manufacturing organization (CDMO) specializing in vaccine discovery and production, launched its first standalone vaccine CDMO site in Suzhou, China. This expansion marks a milestone for the company, introducing increased capabilities for both drug substance and drug product manufacturing. WuXi Vaccines now offers a comprehensive range of services covering diverse vaccines, including process development, drug product development, and the production of clinical-scale drug substances (DS) and small-to-medium sterile drug products (DP). The new standalone site enhances WuXi Vaccines' capacity to contribute to the development and manufacturing of vaccines, playing a pivotal role in advancing global healthcare solutions.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Vaccine Contract Manufacturing Market?

In October 2024, SK bioscience, a South Korea-based vaccine and biotech company, acquired controlling stakes of IDT Biologika for approximately $244 million. This acquisition aligns with SK bioscience's strategy to accelerate growth and aims to drive consolidated sales to KRW 1 trillion (approximately USD 757.6 million) within the next five years. The company also plans to expand further with the launch of next-generation pneumococcal vaccines, positioning itself for continued financial improvement beyond 2028. IDT Biologika, a German-based company vaccine contract development and manufacturing organizations (CDMO).

Regional Outlook

North America was the largest region in the vaccine contract manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the vaccine contract manufacturing market report forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Vaccine Contract Manufacturing Market?

The vaccine contract manufacturing market consists of revenues earned by entities by providing services such as analytical, quality control studies, cell or virus banking, and cold chain services. The market value includes the value of related goods sold by the service provider or included within the service offering. The vaccine contract manufacturing market also includes sales of synthetic vaccines and DNA (deoxyribonucleic acid) vaccines, which are used in providing vaccine contract manufacturing services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Vaccine Contract Manufacturing Market Report 2026?

The vaccine contract manufacturing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the vaccine contract manufacturing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Vaccine Contract Manufacturing Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $4.27 billion
Revenue Forecast In 2035 $6.46 billion
Growth Rate CAGR of 10.0% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Service Type, Vaccine Type, Process, Scale Of Operation, End-Use
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc, Johnson & Johnson, AbbVie Inc., Sanofi, GlaxoSmithKline, Merck KGaA, Moderna, BioNTech, GSK Vaccines, AstraZeneca PLC, Ajinomoto Co. Inc., Lonza Group AG, Catalent Inc., Charles River Laboratories International Inc., Serum Institute of India Pvt. Ltd, Samsung Biologics, WuXi Biologics, Novavax, Sinovac Biotech, Emergent BioSolutions Inc., Bio Farma, Hualan Biological Engineering, BioMARC, Bavarian Nordic A/S, AGC Biologics, IDT Biologika GmbH, Bharat Biotech, Goodwin Biotechnology Inc., Biofabri S.L
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Vaccine Contract Manufacturing Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Vaccine Contract Manufacturing Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Vaccine Contract Manufacturing Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Vaccine Contract Manufacturing Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Industry 4.0 & Intelligent Manufacturing

4.1.3 Sustainability, Climate Tech & Circular Economy

4.1.4 Digitalization, Cloud, Big Data & Cybersecurity

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Outsourcing Of Vaccine Production

4.2.2 Rising Demand For Flexible Manufacturing Capacity

4.2.3 Expansion Of Fill-Finish Service Capabilities

4.2.4 Growing Focus On Regulatory-Compliant Manufacturing

4.2.5 Increasing Adoption Of Single-Use Bioprocessing Systems

5. Vaccine Contract Manufacturing Market Analysis Of End Use Industries

5.1 Vaccine Developers

5.2 Pharmaceutical Companies

5.3 Biotechnology Firms

5.4 Government Health Agencies

5.5 Veterinary Vaccine Producers

6. Vaccine Contract Manufacturing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Vaccine Contract Manufacturing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Vaccine Contract Manufacturing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Vaccine Contract Manufacturing Market Size, Comparisons And Growth Rate Analysis

7.3. Global Vaccine Contract Manufacturing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Vaccine Contract Manufacturing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Vaccine Contract Manufacturing Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Vaccine Contract Manufacturing Market Segmentation

9.1. Global Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Fill-Finish, Bulk Product

9.2. Global Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Inactivated Vaccines, Live-Attenuated Vaccines, RNA (Ribonucleic Acid) Vaccines, Subunit Vaccines, Toxoid-Based Vaccines

9.3. Global Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Downstream, Upstream

9.4. Global Vaccine Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Preclinical, Clinical, Commercial

9.5. Global Vaccine Contract Manufacturing Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Human Use, Veterinary

9.6. Global Vaccine Contract Manufacturing Market, Sub-Segmentation Of Fill-Finish, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Aseptic Fill-Finish, Lyophilization, Vial Filling, Syringe Filling

9.7. Global Vaccine Contract Manufacturing Market, Sub-Segmentation Of Bulk Product, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cell Culture, Microbial Fermentation, Antigen Production, Buffer Preparation

10. Vaccine Contract Manufacturing Market Regional And Country Analysis

10.1. Global Vaccine Contract Manufacturing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Vaccine Contract Manufacturing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Vaccine Contract Manufacturing Market

11.1. Asia-Pacific Vaccine Contract Manufacturing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Vaccine Contract Manufacturing Market, Segmentation By Service Type, Segmentation By Vaccine Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Vaccine Contract Manufacturing Market

12.1. China Vaccine Contract Manufacturing Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Vaccine Contract Manufacturing Market, Segmentation By Service Type, Segmentation By Vaccine Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Vaccine Contract Manufacturing Market

13.1. India Vaccine Contract Manufacturing Market, Segmentation By Service Type, Segmentation By Vaccine Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Vaccine Contract Manufacturing Market

14.1. Japan Vaccine Contract Manufacturing Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Vaccine Contract Manufacturing Market, Segmentation By Service Type, Segmentation By Vaccine Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Vaccine Contract Manufacturing Market

15.1. Australia Vaccine Contract Manufacturing Market, Segmentation By Service Type, Segmentation By Vaccine Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Vaccine Contract Manufacturing Market

16.1. Indonesia Vaccine Contract Manufacturing Market, Segmentation By Service Type, Segmentation By Vaccine Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Vaccine Contract Manufacturing Market

17.1. South Korea Vaccine Contract Manufacturing Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Vaccine Contract Manufacturing Market, Segmentation By Service Type, Segmentation By Vaccine Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Vaccine Contract Manufacturing Market

18.1. Taiwan Vaccine Contract Manufacturing Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Vaccine Contract Manufacturing Market, Segmentation By Service Type, Segmentation By Vaccine Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Vaccine Contract Manufacturing Market

19.1. South East Asia Vaccine Contract Manufacturing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Vaccine Contract Manufacturing Market, Segmentation By Service Type, Segmentation By Vaccine Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Vaccine Contract Manufacturing Market

20.1. Western Europe Vaccine Contract Manufacturing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Vaccine Contract Manufacturing Market, Segmentation By Service Type, Segmentation By Vaccine Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Vaccine Contract Manufacturing Market

21.1. UK Vaccine Contract Manufacturing Market, Segmentation By Service Type, Segmentation By Vaccine Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Vaccine Contract Manufacturing Market

22.1. Germany Vaccine Contract Manufacturing Market, Segmentation By Service Type, Segmentation By Vaccine Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Vaccine Contract Manufacturing Market

23.1. France Vaccine Contract Manufacturing Market, Segmentation By Service Type, Segmentation By Vaccine Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Vaccine Contract Manufacturing Market

24.1. Italy Vaccine Contract Manufacturing Market, Segmentation By Service Type, Segmentation By Vaccine Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Vaccine Contract Manufacturing Market

25.1. Spain Vaccine Contract Manufacturing Market, Segmentation By Service Type, Segmentation By Vaccine Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Vaccine Contract Manufacturing Market

26.1. Eastern Europe Vaccine Contract Manufacturing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Vaccine Contract Manufacturing Market, Segmentation By Service Type, Segmentation By Vaccine Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Vaccine Contract Manufacturing Market

27.1. Russia Vaccine Contract Manufacturing Market, Segmentation By Service Type, Segmentation By Vaccine Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Vaccine Contract Manufacturing Market

28.1. North America Vaccine Contract Manufacturing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Vaccine Contract Manufacturing Market, Segmentation By Service Type, Segmentation By Vaccine Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Vaccine Contract Manufacturing Market

29.1. USA Vaccine Contract Manufacturing Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Vaccine Contract Manufacturing Market, Segmentation By Service Type, Segmentation By Vaccine Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Vaccine Contract Manufacturing Market

30.1. Canada Vaccine Contract Manufacturing Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Vaccine Contract Manufacturing Market, Segmentation By Service Type, Segmentation By Vaccine Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Vaccine Contract Manufacturing Market

31.1. South America Vaccine Contract Manufacturing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Vaccine Contract Manufacturing Market, Segmentation By Service Type, Segmentation By Vaccine Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Vaccine Contract Manufacturing Market

32.1. Brazil Vaccine Contract Manufacturing Market, Segmentation By Service Type, Segmentation By Vaccine Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Vaccine Contract Manufacturing Market

33.1. Middle East Vaccine Contract Manufacturing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Vaccine Contract Manufacturing Market, Segmentation By Service Type, Segmentation By Vaccine Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Vaccine Contract Manufacturing Market

34.1. Africa Vaccine Contract Manufacturing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Vaccine Contract Manufacturing Market, Segmentation By Service Type, Segmentation By Vaccine Type, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Vaccine Contract Manufacturing Market Regulatory and Investment Landscape

36. Vaccine Contract Manufacturing Market Competitive Landscape And Company Profiles

36.1. Vaccine Contract Manufacturing Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Vaccine Contract Manufacturing Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Vaccine Contract Manufacturing Market Company Profiles

36.3.1. Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

36.3.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Sanofi Overview, Products and Services, Strategy and Financial Analysis

36.3.5. GlaxoSmithKline Overview, Products and Services, Strategy and Financial Analysis

37. Vaccine Contract Manufacturing Market Other Major And Innovative Companies

Merck KGaA, Moderna, BioNTech, GSK Vaccines, AstraZeneca PLC, Ajinomoto Co. Inc., Lonza Group AG, Catalent Inc., Charles River Laboratories International Inc., Serum Institute of India Pvt. Ltd, Samsung Biologics, WuXi Biologics, Novavax, Sinovac Biotech, Emergent BioSolutions Inc.

38. Global Vaccine Contract Manufacturing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Vaccine Contract Manufacturing Market

40. Vaccine Contract Manufacturing Market High Potential Countries, Segments and Strategies

40.1 Vaccine Contract Manufacturing Market In 2030 - Countries Offering Most New Opportunities

40.2 Vaccine Contract Manufacturing Market In 2030 - Segments Offering Most New Opportunities

40.3 Vaccine Contract Manufacturing Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Vaccine Contract Manufacturing Market, Overview Of Key Products - Product Examples
  • Table 2: Global Vaccine Contract Manufacturing Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Vaccine Contract Manufacturing Market, Supply Chain Analysis
  • Table 4: Global Vaccine Contract Manufacturing Market, Major Raw Material Providers
  • Table 5: Global Vaccine Contract Manufacturing Market, Major Resource Providers
  • Table 6: Global Vaccine Contract Manufacturing Market, Major Manufacturers (Suppliers)
  • Table 7: Global Vaccine Contract Manufacturing Market, Major Distributors And Channel Partners
  • Table 8: Global Vaccine Contract Manufacturing Market, Key Technologies & Future Trends
  • Table 9: Global Vaccine Contract Manufacturing Market, Major Trends
  • Table 10: Global Vaccine Contract Manufacturing Market, Major End Users
  • Table 11: Global Vaccine Contract Manufacturing Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Vaccine Contract Manufacturing Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Vaccine Contract Manufacturing Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Vaccine Contract Manufacturing Market - TAM, US$ Billion, 2025
  • Table 15: Global Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Vaccine Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Vaccine Contract Manufacturing Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Vaccine Contract Manufacturing Market, Sub-Segmentation Of Fill-Finish, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Vaccine Contract Manufacturing Market, Sub-Segmentation Of Bulk Product, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Vaccine Contract Manufacturing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Vaccine Contract Manufacturing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Global Vaccine Contract Manufacturing Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 97: Global Vaccine Contract Manufacturing Market - Company Scoring Matrix
  • Table 98: Pfizer Inc Financial Performance
  • Table 99: Johnson & Johnson Financial Performance
  • Table 100: AbbVie Inc. Financial Performance
  • Table 101: Sanofi Financial Performance
  • Table 102: GlaxoSmithKline Financial Performance
  • Table 103: Global Vaccine Contract Manufacturing Market, Competitive Benchmarking (In USD Billions)
  • Table 104: Global Vaccine Contract Manufacturing Market, Competitive Dashboard
  • Table 105: Global Vaccine Contract Manufacturing Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 106: Global, Vaccine Contract Manufacturing Market Size Gain ($ Billion), Segmentation By Service Type, 2025 – 2030
  • Table 107: Global, Vaccine Contract Manufacturing Market Size Gain ($ Billion), Segmentation By Vaccine Type, 2025 – 2030
  • Table 108: Global, Vaccine Contract Manufacturing Market Size Gain ($ Billion), Segmentation By Process, 2025 – 2030

List Of Figures

    Figure 1: Global Vaccine Contract Manufacturing Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Vaccine Contract Manufacturing Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Vaccine Contract Manufacturing Market, Supply Chain Analysis
  • Figure 4: Global Vaccine Contract Manufacturing Market, Major Raw Material Providers
  • Figure 5: Global Vaccine Contract Manufacturing Market, Major Resource Providers
  • Figure 6: Global Vaccine Contract Manufacturing Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Vaccine Contract Manufacturing Market, Major Distributors And Channel Partners
  • Figure 8: Global Vaccine Contract Manufacturing Market, Key Technologies & Future Trends
  • Figure 9: Global Vaccine Contract Manufacturing Market, Major Trends
  • Figure 10: Global Vaccine Contract Manufacturing Market, Major End Users
  • Figure 11: Global Vaccine Contract Manufacturing Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Vaccine Contract Manufacturing Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Vaccine Contract Manufacturing Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Vaccine Contract Manufacturing Market - TAM, US$ Billion, 2025
  • Figure 15: Global Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Vaccine Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Vaccine Contract Manufacturing Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Vaccine Contract Manufacturing Market, Sub-Segmentation Of Fill-Finish, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Vaccine Contract Manufacturing Market, Sub-Segmentation Of Bulk Product, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Vaccine Contract Manufacturing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Vaccine Contract Manufacturing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Global Vaccine Contract Manufacturing Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 97: Global Vaccine Contract Manufacturing Market - Company Scoring Matrix
  • Figure 98: Pfizer Inc Financial Performance
  • Figure 99: Johnson & Johnson Financial Performance
  • Figure 100: AbbVie Inc. Financial Performance
  • Figure 101: Sanofi Financial Performance
  • Figure 102: GlaxoSmithKline Financial Performance
  • Figure 103: Global Vaccine Contract Manufacturing Market, Competitive Benchmarking (In USD Billions)
  • Figure 104: Global Vaccine Contract Manufacturing Market, Competitive Dashboard
  • Figure 105: Global Vaccine Contract Manufacturing Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 106: Global, Vaccine Contract Manufacturing Market Size Gain ($ Billion), Segmentation By Service Type, 2025 – 2030
  • Figure 107: Global, Vaccine Contract Manufacturing Market Size Gain ($ Billion), Segmentation By Vaccine Type, 2025 – 2030
  • Figure 108: Global, Vaccine Contract Manufacturing Market Size Gain ($ Billion), Segmentation By Process, 2025 – 2030

Key Developments and Trends Steering the Eye Infections Market Forward: Advancing Eye Infection Therapies The Role Of Photodynamic Treatment And Strategic Collaborations

Read More About Key Developments and Trends Steering the Eye Infections Market Forward: Advancing Eye Infection Therapies The Role Of Photodynamic Treatment And Strategic Collaborations

Major Trends and Emerging Patterns in the Febrile Neutropenia Market: Advancement In Biosimilar Drugs For Febrile Neutropenia Treatment

Read More About Major Trends and Emerging Patterns in the Febrile Neutropenia Market: Advancement In Biosimilar Drugs For Febrile Neutropenia Treatment

Key Factors Fueling the Growth of the Filariasis Treatment Market in 2025: Rising Incidence Of Elephantiasis Driving Growth In The Market

Read More About Key Factors Fueling the Growth of the Filariasis Treatment Market in 2025: Rising Incidence Of Elephantiasis Driving Growth In The Market

Critical Market Drivers Shaping the Outlook for Gastroesophageal Junction Adenocarcinoma Therapeutics Market from 2025-2034: Impact Of Growing Obesity Cases On The Market

Read More About Critical Market Drivers Shaping the Outlook for Gastroesophageal Junction Adenocarcinoma Therapeutics Market from 2025-2034: Impact Of Growing Obesity Cases On The Market

Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Read More About Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Explore market drivers and forecast in the nasal spray influenza vaccine sector through 2025–2034.

Read More About Explore market drivers and forecast in the nasal spray influenza vaccine sector through 2025–2034.

Review key data-driven trends shaping the global data storage market in 2025.

Read More About Review key data-driven trends shaping the global data storage market in 2025.

Analyze the 6.7% CAGR growth trajectory and strategic trends shaping the global medical glass vaccine bottles market through 2029.

Read More About Analyze the 6.7% CAGR growth trajectory and strategic trends shaping the global medical glass vaccine bottles market through 2029.

Vaccines Global Market Report 2022 – By Type (Anti-Infective Vaccines, Autoimmunity, Others (Cancer And Others)), By Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant...

Isotretinoin Drugs Market Report 2026 - Global Outlook – By Form (Capsules, Injection), By Indication Type (Severe Acne, Neuroblastoma, Cutaneous T-Cell Lymphoma, Harlequin Ichthyosis, Xeroderma Pigmentosum, Fibrodysplas...

UV Disinfection Equipment Market Report 2026 - Global Outlook – By Component (UV Lamp, Controller Unit, Quartz Sleeve, Reactor Chamber, Other Components ), By Power Rating (Low, Medium, High ), By Application (Water Trea...

Function-as-a-Service Market Report 2026 - Global Outlook – By Deployment Model (Public Cloud, Private Cloud, Hybrid Cloud), By Enterprise Size (Small And Medium Enterprises, Large Enterprises), By End-User (Banking, Fin...

Genu Recurvatum Market Report 2026 - Global Outlook – By Type (External Rotatory Deformity (ERD), Internal Rotatory Deformity (IRD), Non-Rotatory Deformity (NRD)), By Diagnosis (Magnetic Resonance Imaging (MRI), X-Rays, ...

Bearing Steel Market Report 2026 - Global Outlook – By Product Type (High Carbon Chromium, Carburizing, High Temperature), By Application (Ball Bearings, Roller Bearings, Thrust Bearings, Other Applications), By End Use ...

Frequently Asked Questions

The Vaccine Contract Manufacturing Market Report 2026 market was valued at $3.88 billion in 2025, increased to $4.27 billion in 2026, and is projected to reach $6.46 billion by 2030. request a sample here

The expected CAGR for the Vaccine Contract Manufacturing Market Report 2026 market during the forecast period 2025–2030 is 10.9%. request a sample here

Major growth driver of the market includes: Elevated Infectious Disease Cases Propel Expansion In The Vaccine Contract Manufacturing Market in the Vaccine Contract Manufacturing Market Report 2026 market. For further insights on this market, request a sample here

The vaccine contract manufacturing market covered in this report is segmented –
1) By Service Type: Fill-Finish, Bulk Product
2) By Vaccine Type: Inactivated Vaccines, Live-Attenuated Vaccines, RNA (Ribonucleic Acid) Vaccines, Subunit Vaccines, Toxoid-Based Vaccines
3) By Process: Downstream, Upstream
4) By Scale Of Operation: Preclinical, Clinical, Commercial
5) By End-Use: Human Use, Veterinary Subsegments:
1) By Fill-Finish: Aseptic Fill-Finish, Lyophilization, Vial Filling, Syringe Filling
2) By Bulk Product: Cell Culture, Microbial Fermentation, Antigen Production, Buffer Preparation request a sample here

Major trend in this market includes: Strategic Expansion With The Standalone Vaccine Contract Manufacturing Site For further insights on this market, request a sample here.

Major companies operating in the Vaccine Contract Manufacturing Market Report 2026 market are Major companies operating in the vaccine contract manufacturing market are Pfizer Inc, Johnson & Johnson, AbbVie Inc., Sanofi, GlaxoSmithKline, Merck KGaA, Moderna, BioNTech, GSK Vaccines, AstraZeneca PLC, Ajinomoto Co. Inc., Lonza Group AG, Catalent Inc., Charles River Laboratories International Inc., Serum Institute of India Pvt. Ltd, Samsung Biologics, WuXi Biologics, Novavax, Sinovac Biotech, Emergent BioSolutions Inc., Bio Farma, Hualan Biological Engineering, BioMARC, Bavarian Nordic A/S, AGC Biologics, IDT Biologika GmbH, Bharat Biotech, Goodwin Biotechnology Inc., Biofabri S.L request a sample here.

North America was the largest region in the vaccine contract manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the vaccine contract manufacturing market report forecast period. The regions covered in the vaccine contract manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us